CASM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CASM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
CAS Medical Systems's change in receivables for the quarter that ended in Dec. 2018 was $0.18 Mil. It means CAS Medical Systems's Accounts Receivable declined by $0.18 Mil from Sep. 2018 to Dec. 2018 .
CAS Medical Systems's change in receivables for the fiscal year that ended in Dec. 2018 was $-0.26 Mil. It means CAS Medical Systems's Accounts Receivable increased by $0.26 Mil from Dec. 2017 to Dec. 2018 .
CAS Medical Systems's Accounts Receivable for the quarter that ended in Dec. 2018 was $3.18 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CAS Medical Systems's Days Sales Outstanding for the three months ended in Dec. 2018 was 50.06.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CAS Medical Systems's liquidation value for the three months ended in Dec. 2018 was $-6.95 Mil.
The historical data trend for CAS Medical Systems's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAS Medical Systems Annual Data | |||||||||||||||||||||
Trend | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | -1.00 | -0.45 | -0.91 | 0.39 | -0.26 |
CAS Medical Systems Quarterly Data | ||||||||||||||||||||
Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | |
Change In Receivables | Get a 7-Day Free Trial | 0.05 | 0.21 | -0.27 | -0.39 | 0.18 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAS Medical Systems (NAS:CASM) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
CAS Medical Systems's Days Sales Outstanding for the quarter that ended in Dec. 2018 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 3.183 | / | 5.802 | * | 91 |
= | 50.06 |
2. In Ben Graham's calculation of liquidation value, CAS Medical Systems's accounts receivable are only considered to be worth 75% of book value:
CAS Medical Systems's liquidation value for the quarter that ended in Dec. 2018 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 3.272 | - | 13.113 | + | 0.75 * 3.183 | + | 0.5 * 1.012 |
= | -6.95 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of CAS Medical Systems's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Alan Milinazzo | director | C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078 |
Thomas M Patton | director, officer: President and CEO | C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724 |
Kenneth R Weisshaar | director | 875 PARK AVE APT 2D, NEW YORK NY 10021 |
James E Thomas | director, 10 percent owner | WOODS END ROAD, NEW CANAAN CT 06840 |
Thomas, Mcnerney & Partners Ii L.p. | 10 percent owner | 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402 |
Tmp Associates Ii Lp | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Tmp Nominee Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Thomas, Mcnerney & Partners Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Acuta Capital Fund, Lp | 10 percent owner | 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 |
James E Flynn | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Management Company, L.p. (series C) | 10 percent owner, other: Possible Member of 10% Group | 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010 |
Deerfield Mgmt L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Special Situations Fund, L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Special Situations International Master Fund, L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Lawrence Burstein | director | C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016 |
From GuruFocus
By PRNewswire PRNewswire • 03-19-2019
By PRNewswire PRNewswire • 03-05-2019
By PRNewswire PRNewswire • 02-15-2019
By Marketwired Marketwired • 05-03-2018
By Marketwired Marketwired • 05-29-2018
By Marketwired Marketwired • 03-28-2019
By PRNewswire PRNewswire • 03-14-2019
By gurufocus 10qk • 05-05-2010
By gurufocus 10qk • 11-05-2009
By Marketwired Marketwired • 10-24-2018
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.